Sanofi

Sanofi, Bristol Shake up Alliance as Patents End

Sanofi to Buy Colombian Drugmaker Genfar

Sanofi Appoints Dr. Paul Chew Chief Medical Officer

The European Pharmaceuticals Economy at Halftime 2012

Topics • Technology

Thriving Generics

Sanofi to Unveil Plans for French Research Shake-up

German Biotech Investor Bets $105 Million More on CureVac

Momenta Set Back as Court Lifts Blood Clot Drug Halt

EU Crisis Piles on Pain for Europe's Drugmakers

Drugmakers Brace for More Pain, Some Gain in France

FDA OKs First Obesity Drug in 13 years

Novo Nordisk Hit by U.S. Delay to New Insulin Drug

Sanofi Aims to Expand in Diabetes Market

Drugmaker Amylin Draws Initial Bids

Sanofi Strong in Emerging Markets as Rivals Flag

Amgen to Buy Turkish Drugmaker for $700 mln

EU Supports Novartis MS Pill with Stronger Warning

Teva Launches Generic High Blood Pressure Drugs

French Drugs Market to Shrink in 2012

Sanofi to Close Northeast England Plant

Bayer Sounds Out Debt Market with Eye On Deals

Topics • Technology

Atlanta – The Center for Global Health

Pharma Asks The Money Question Earlier For New Drugs

AstraZeneca, Novartis and Sanofi Douse Hopes For New Drugs

Global Pharma to Pump Cash Into Russia

Sanofi Pasteur Acquires Worldwide License For Acne Vaccine, Treatment

Sanofi Wins U.S. Cancer Drug Eloxatin Patent Litigation

Sanofi-Aventis Q2 Profit Slips

E&Y Sees $1-5 Billion As Sweet Spot For Biotech M&A

Sanofi Weighing Options For U.S. Dermatology Unit

Sanofi Completes Genzyme Takeover

Sanofi Says Gains Control Of Genzyme

Sanofi CVRs Tied To Genzyme May Start Trading April 4

Chris Viehbacher: Sanofi to Grow Animal Health Through Bolt-On Buys

Merck, Sanofi Cancel Planned Animal-Health JV

101 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.